Colin Eldred
Coventry Health Care
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Colin Eldred.
Tetrahedron Letters | 2002
Heather Tye; Colin Eldred; Martin Wills
Abstract A simple method for the preparation of N,N′-dimethyl-1,2-diamines is described. The method requires the dimethylation of a diazaphospholidine oxide followed by acid-catalysed hydrolysis.
Progress in Medicinal Chemistry | 1999
Colin Eldred; Brian David Judkins
Publisher Summary This chapter discusses the design and clinical applications of fibrinogen receptor antagonists. The concept of a fibrinogen receptor antagonist as a powerful new antithrombotic mechanism arose from consideration of the central role of the platelet in thrombosis. In healthy blood vessels, “resting” platelets do not adhere to the nonthrombogenic surface of intact endothelium. However, platelets can adhere to subendothelial structures of a damaged vessel wall, for example, following rupture of an atherosclerotic plaque, resulting in initiation of the process of clot formation. The fibrinogen receptor represents the best characterized member of the integrin family of cell adhesion receptors, which are involved in a wide variety of cell–cell and cell-extracellular matrix interactions. The pharmacodynamic duration of action of fibrinogen antagonists has generally been assessed by measuring inhibition of platelet aggregation ex vivo in samples of blood taken at intervals following i.v. or p.o. administration of drug, for example in the marmoset. The most common approach used to increase bioavailability of fibrinogen antagonists is to mask one or both of the charged entities thereby increasing log D and increasing the likelihood of absorption through lipophilic membranes. In addition to studying the ability of fibrinogen antagonists to prevent thrombus formation, the ability of these agents to enhance the outcome of thrombolytic therapy has been studied in several animal models, in which thrombolysis alone is only partially effective and/or is followed by rapid reocclusion.
Journal of The Chemical Society-perkin Transactions 1 | 2001
Donald Smyth; Heather Tye; Colin Eldred; Nathaniel W. Alcock; Martin Wills
The synthesis of a series of closely related mono- and bis(diazaphospholidine) ligands has been achieved using the condensation of a diamine with a bis(dimethylamino)arylphosphine. The resulting ligands have given excellent results in palladium-catalysed allylic substitution reactions to form C–C bonds (up to 89% ee) and C–N bonds (up to 78% ee).
Journal of The Chemical Society-perkin Transactions 1 | 1998
Heather Tye; Colin Eldred; Martin Wills
The design and synthesis of a novel class of chiral receptor for the recognition of amino acid derivatives is described. Moderate enantioselectivity is observed in binding experiments.
Chemical Communications | 1997
Heather Tye; Donald Smyth; Colin Eldred; Martin Wills
The synthesis and applications to allylic substitutions of a range of novel ligands based on diazaphospholidines is described; enantiomeric excesses of up to 89% were achieved in an allylic substitution reaction.
Chemical Communications | 1997
Heather Tye; Donald Smyth; Colin Eldred; Martin Wills
Archive | 1997
David George Allen; Colin Eldred; Brian David Judkins; William Leonard Mitchell; David Ian Carter Scopes
Archive | 1993
David Middlemiss; Brian David Judkins; Colin Eldred; Barry Porter; Henry Anderson Kelly
Archive | 2002
David Edmund Bays; Richard Peter Charles Cousins; Hazel Joan Dyke; Colin Eldred; Brian David Judkins; Martin Pass; Andrew Michael Kenneth Pennell
Synlett | 1995
Heather Tye; Colin Eldred; Martin Wills